B2M and non-proliferative diabetic retinopathy: B2M is also a tear protein expressed in patients suffering from DR, and its levels have been proven to be elevated by proteomic analysis in NPDR patients compared to healthy volunteers; it is thus considered a possible biomarker of early DR (32).